Optimal Timing of Photobiomodulation Therapy for Retinal Diseases: Leveraging Circadian Mitochondrial Rhythms.
Abstract
Age-related retinal degeneration is associated with mitochondrial dysfunction. Emerging evidence suggests that photobiomodulation therapy (PBMT) using near-infrared light may improve mitochondrial function and visual performance, but its efficacy is critically time-dependent. This article explores how daily biological rhythms and mitochondrial function interact, focusing on the potential of timed PMBT for age-related eye diseases. Further research is needed to determine optimal treatment times and individual responses to maximize this therapy's benefits.
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
The paper claims that the timing of photobiomodulation therapy can enhance its efficacy for treating age-related retinal diseases by aligning treatment with circadian mitochondrial rhythms. This research is relevant as it addresses a potential intervention that could improve mitochondrial function, which is a key aspect of aging and age-related diseases.
Author of this paper? Send a correction.